129 related articles for article (PubMed ID: 23071006)
21. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
22. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
23. Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors.
Griscelli F; Gilardi-Hebenstreit P; Hanania N; Franz WM; Opolon P; Perricaudet M; Ragot T
Hum Gene Ther; 1998 Sep; 9(13):1919-28. PubMed ID: 9741430
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.
Brooks AR; Harkins RN; Wang P; Qian HS; Liu P; Rubanyi GM
J Gene Med; 2004 Apr; 6(4):395-404. PubMed ID: 15079814
[TBL] [Abstract][Full Text] [Related]
25. Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10.
Dronadula N; Wacker BK; Van Der Kwast R; Zhang J; Dichek DA
Hum Gene Ther; 2017 Mar; 28(3):255-270. PubMed ID: 27842439
[TBL] [Abstract][Full Text] [Related]
26. DNA context and promoter activity affect gene expression in lentiviral vectors.
Mao G; Marotta F; Yu J; Zhou L; Yu Y; Wang L; Chui D
Acta Biomed; 2008 Dec; 79(3):192-6. PubMed ID: 19260378
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.
Kimura T; Koya RC; Anselmi L; Sternini C; Wang HJ; Comin-Anduix B; Prins RM; Faure-Kumar E; Rozengurt N; Cui Y; Kasahara N; Stripecke R
Mol Ther; 2007 Jul; 15(7):1390-9. PubMed ID: 17505480
[TBL] [Abstract][Full Text] [Related]
28. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.
Nalbantoglu J; Larochelle N; Wolf E; Karpati G; Lochmuller H; Holland PC
J Virol; 2001 May; 75(9):4276-82. PubMed ID: 11287577
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
30. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
31. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
32. Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors.
Gruh I; Wunderlich S; Winkler M; Schwanke K; Heinke J; Blömer U; Ruhparwar A; Rohde B; Li RK; Haverich A; Martin U
J Gene Med; 2008 Jan; 10(1):21-32. PubMed ID: 18022932
[TBL] [Abstract][Full Text] [Related]
33. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
34. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
35. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
36. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
37. Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy.
Ribault S; Neuville P; Méchine-Neuville A; Augé F; Parlakian A; Gabbiani G; Paulin D; Calenda V
Circ Res; 2001 Mar; 88(5):468-75. PubMed ID: 11249869
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
39. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.
Arita E; Kondoh M; Isoda K; Nishimori H; Yoshida T; Mizuguchi H; Yagi K
Eur J Pharm Biopharm; 2008 Sep; 70(1):1-6. PubMed ID: 18468873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]